Feature Article

Acral Melanoma: Clinical Advances and Hope for the Future

Abstract: Acral melanoma is a rare subtype of melanoma with unique histologic and biologic characteristics. Given its relative rarity compared with nonacral cutaneous melanoma, acral melanoma […]

Feature Article

Neoadjuvant Immunotherapy in Resectable Non–Small Cell Lung Cancer

Abstract: Lung cancer is the leading cause of cancer-related deaths worldwide and is associated with poor 5-year outcomes, even among the 20% to 25% of patients […]

Letter From the Editor

Letter From the Editor: Dog Traits

Mojo, our family dog, passed away last month. Losing her made me realize what a valuable emotional support she had been for our family. As our […]

LLM

Recent Approval of Pirtobrutinib for Mantle Cell Lymphoma

H&O What is pirtobrutinib and how does it work? JC Pirtobrutinib (Jaypirca, Lilly) is a recently approved therapy for patients with relapsed or refractory mantle cell […]

Prostate Cancer In Focus

More Highlights in Prostate Cancer From the 2023 American Society of Clinical Oncology Annual Meeting

June 2-6, 2023 • Chicago, Illinois and Virtual Last month, Clinical Advances in Hematology & Oncology highlighted the PEACE-1 trial, the TALAPRO-2 study, and research on […]

Lung Cancer in Focus

Updates in Small Cell Lung Cancer

H&O How common is small cell lung cancer (SCLC), and who is at risk? JS Lung cancer is the second most common cancer type in men […]

Melanoma in Focus

Adjuvant Therapy in High-Risk, Node-Negative Melanoma

H&O Which patients with high-risk, node-negative melanoma should receive adjuvant therapy? MR First, it is important to define what is meant by “high-risk,” or what the […]

Advances in Drug Development

Novel Sources of Funding for Clinical Trials in Oncology

H&O What are the traditional sources of funding for clinical trials in oncology, and how have they evolved over time? GS Traditional sources of funding for […]

CLL

Management of Richter Transformation

H&O How often does chronic lymphocytic leukemia (CLL) transform into aggressive lymphoma? MD Transformation of CLL into aggressive lymphoma, known as Richter transformation (RT), is relatively […]